From BZ’s Small Cap Healthcare Conference: Inspira Technologies Co-Founder & CFO, Joe Hayon Begins Speaking
Click To Tune In Here... https://www.benzinga.com/events/small-cap/healthcare/
urban-gro Announces Upcoming Investor Events
urban-gro's MJ12 Design Studio to exhibit at the NECANN New Jersey Conference on October 2-3
Alliance Global Partners Virtual Fall Consumer Cannabis Conference will feature one-on-one and small group
Neoleukin Therapeutics Announces Oral Presentation At IDWeek 2021 Of Data Demonstrating That NL-CVX1, A Computationally Designed De Novo Protein, Can Block Infection By SARS-CoV-2 Viral Variants of Concern
Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced new data
Humanigen Announces Oral Presentation of Lenzilumab LIVE-AIR Phase 3 Study Results At IDWeek 2021
Humanigen, Inc. (NASDAQ:HGEN), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm' with its lead drug candidate, lenzilumab, today
GAN To Host Investor Event in Las Vegas, Nevada On Oct. 4, 2021
GAN's executive leadership team to provide insight into the Company's business opportunities and long-term outlook
GAN Limited (the "Company" or "GAN") (NASDAQ:GAN), a leading
NeuBase Therapeutics To Present At Chardan Genetic Medicines Conference Oct. 5 At 11:30 a.m. EDT
NeuBase Therapeutics, Inc. (NASDAQ:NBSE) (“NeuBase”), a biotechnology platform company Drugging the Genome™ to address disease at the base level using a new class of precision genetic medicines,
PGA Tour, Rocket Mortgage Look To Help Fuel Detroit’s Recovery
The PGA Tour and Rocket Mortgage by Rocket Companies Inc (NYSE: RKT) have extended the title sponsorship for the Rocket Mortgage Classic through 2027.
Vaxcyte To Present At Guggenheimer Vaccine, Infectious Disease Conference Tuesday, Oct. 5, 2021 At 11:30 a.m. EDT
Vaxcyte, Inc. (NASDAQ:PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious
Wave Life Sciences Announces New Data For Leading RNA Editing Capability Across Multiple Tissues, Provides Update On AATD Program During Analyst And Investor Research Webcast
Wave Life Sciences Ltd. (NASDAQ:WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, today presented new data for its ADAR-mediated
BioCryst Shares Down ~2.5% Ahead Of Co.’s 2 p.m. EDT Presentation At Cantor’s Global Healthcare Conference
https://wsw.com/webcast/cantor12/register.aspx?conf=cantor12&page=bcrx&url=https://wsw.com/webcast/cantor12/bcrx/2084950